Snapshot

The Abridged Registration pathway has been developed by the Drug Regulatory Authority Kingdom of Bhutan of Bhutan.

It is an abridged review (a reliance pathway).

When relevant, the agency relies on prior decisions from Australia Canada EU-EMA Japan Malaysia Singapore Thailand United Kingdom United States WHO

Review of applications will follow a queue system. However, the Authority may fast-track the registration under exceptional circumstances as deemed appropriate.